March 30, 2022

Innovating in Oncology: Meet the Startup Innovators Fueling the Future for Cancer Treatment

Some of tomorrow’s biggest breakthroughs in cancer treatment are in the works today in startup labs across the US. On March 30, we brought together CEOs and leaders in the cancer startup industry for a behind-the-scenes look at how emerging technologies are taking aim at one of the deadliest diseases in our world, and how these startup leaders are carving successful careers in the cancer tech landscape.

We were honored to welcome Dr. Greg Evans, National Cancer Institute Program Director and Team Leader, for a fireside chat with Phase Genomics CEO and Co-Founder Dr. Ivan Liachko.  Their insights shed light on the funding process behind emerging technologies and how to start on the road to success.

Thank you to our speakers

Greg
Evans

Program Director at the National Cancer Institute

Lindsay
Pino

CTO & Cofounder at Talus Bio

Emmanuel
Akporiaye

Founder and CEO at Veana Therapeutics Inc

Trevor
Levin

Founder & CEO at Convergent Genomics

Photo of man in black and white

Ivan
Liachko

Founder & CEO at Phase Genomics

Molika
Ashford

Editor at GenomeWeb

Join the community and stay informed